Tiludronate Disodium Hydrate
替鲁膦酸二钠
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameTiludronate Disodium Hydrate
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1995/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A
Develop Information
Active CompaniesSanofi
Inactive CompaniesSanofi-Aventis U.S. Llc
Active Indications
Inactive IndicationsN/A